- 专利标题： PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII
-
申请号： US17849879申请日： 2022-06-27
-
公开(公告)号： US20220324999A1公开(公告)日： 2022-10-13
- 发明人: Koichiro Yoneyama
- 申请人： CHUGAI SEIYAKU KABUSHIKI KAISHA
- 申请人地址： JP Tokyo
- 专利权人： CHUGAI SEIYAKU KABUSHIKI KAISHA
- 当前专利权人： CHUGAI SEIYAKU KABUSHIKI KAISHA
- 当前专利权人地址： JP Tokyo
- 优先权： JP2014-127240 20140620,JP2014-226988 20141107
- 主分类号： C07K16/36
- IPC分类号： C07K16/36 ; A61K39/395 ; C07K16/46
摘要：
The inventors discovered that by administering a pharmaceutical composition comprising a bispecific antigen-binding molecule that recognizes blood coagulation factor IX and/or activated blood coagulation factor IX and blood coagulation factor X and/or activated blood coagulation factor X according to a given dosage regimen, diseases that develop and/or progress due to a decrease or deficiency in the activity of blood coagulation factor VIII and/or activated blood coagulation factor VIII can be prevented and/or treated more effectively.
信息查询
